15th Annual Meeting: Agenda

This educational session will focus on avoiding the pitfalls of fraud and abuse in a professional setting, discussing what physicians need to know to avoid unintentionally committing fraud and abuse. This session will also touch on updates within the KBML and how will it affect your practice.

KY-ACC’s Quality Coalition facilitates the statewide exchange of information and knowledge to improve patient outcomes in Kentucky. To that end, KY-ACC is pleased to host the Third Annual Quality Summit and Dinner on Friday, October 11, 2019.

Objectives:

• Advance knowledge around the clinical utility of coronary CTA in 2019

Session Chair: Khaled Ziada, MD, FACC, FSCAI
Moderators: Amir Piracha, MD and Michael Winkler, MD

Session Chairs: Khaled Ziada, MD, FACC, FSCAI and Susan Smyth, MD, PhD, FACC
Moderators: Hassan Reda, MD and Mohammed Kazimuddin, MD

Recipient: Jesse Adams, MD, FACC is an adult cardiologist with Baptist Health in Louisville. He was the lead author on the original clinical validation studies for cardiac troponin I and has published numerous scientific papers as well as editing two textbooks on markers in cardiology. He has served as the president of the Kentuckiana Metro chapter of the American Heart Association. He also has served in numerous roles and committees with the American College of Cardiology, including Governor for the Kentucky chapter. He currently serves on the Executive Council for the CV Management Section of the ACC and is chair of the CV Management Section’s Publication Writing Group.

Moderator: John Mandrola, MD

Objectives:

• Discuss issues and resources available, relevant to the challenges that cardiologists face in career development

Moderators: Jacqueline Dawson Dowe, MD, FACC and Chris Betz, PharmD, BCPS, FKSHP, FASHP
Session Chair: Vedant Gupta, MD

Objectives:

• Describe the ACC strategic plan with regard to efforts at diversity and inclusion.
• Understand the definition of those groups who are underrepresented in cardiology.
• Explain the goals and metrics of the ACC Task Force on Diversity and Inclusion.

Session Chairs: Susan Smyth, MD, PhD, FACC and Craig J. Beavers, PharmD, FACC, FAHA, BCCP, BCPS (AQ-Cardiology), CACP
Moderators: Susan Smyth, MD, PhD, FACC and Craig J. Beavers, PharmD, FACC, FAHA, BCCP, BCPS (AQ-Cardiology), CACP

Objectives:

• Describe the types of ventricular septal defects
• Explain the best echocardiographic views of each defect
• Describe the physiologic assessment of VSD by echo

Moderator: Juan Villafane, MD
Session Chair: John Kotter, MD

Objectives:

• Describe the types of ASD’s and the associated repairs. Imaging views and complications

Moderator: Juan Villafane, MD
Session Chair: John Kotter, MD

Objectives:

• Understand the typical echocardiographic findings of L-TGA
• Know how to differentiate left ventricle from right ventricle in complex congenital heart disease
• Recognize an unusual complication of L-TGA

Moderator: Majd Makhoul, MD
Session Chair: Marcus Stoddard, MD, FACC, FAHA

Objectives:

• Review the complete echocardiographic assessment of tetralogy of Fallot
• Describe the associated lesions and their diagnostic methods

Moderator: Majd Makhoul, MD
Session Chair: Marcus Stoddard, MD, FACC, FAHA

Objectives:

• Describe reasons for current change in status allocation
• Explain each status (1-6) and the requirements for listing
• Understand the impact of the change made to the allocation system

Moderator: Steven Heatherly, MD
Session Chair: Andrew Kolodziej, MD

Moderator: Steven Heatherly, MD
Session Chair: Andrew Kolodziej, MD

Objectives:

• To educate on specifics of current LVAD data
• To understand the data on morbidity and mortality

Session Chair: Emma Birks, MD, PhD, FRCP

Objectives:

• Participants will be able to describe management techniques in managging VA ECLS patients
• Participants will recognize and describe common complications associated with managing VA ECMO patients
• Participants will be able to describe indicatos for successful weaning and separation from VA ECMO

Session Chair: Emma Birks, MD, PhD, FRCP

Objectives:

• Understanding basic HIS Bundle Pacing
• Understanding the evidence of HIS Bundle Pacing
• Review the challenges going forward of HIS Bundle Pacing

Moderator: Michael Faulkner, MD
Session Chair: Kevin Parrot, MD

Objectives:

• To present our experience with development of a collaborative hybrid ablation program between Cardiothoracic Surgery and Cardiac Electrophysiology for treatment of long standing persistent atrial fibrillation
• Report on our single center outcomes after over 2 years

Moderator: Michael Faulkner, MD
Session Chair: Kevin Parrot, MD

Objectives:

• Familiarize audience with options for device therapy
• Appropriate patient selection and indication for new devices
• Introduce future direction to optimize those devices

Moderator: Leslie McDonogh
Session Chair: Hussam Hamdalla, MD

Objectives:

• Review the CHADSVASC score components
• Describe updates to the guidelines regarding anticoagulation strategies
• Discuss new atrial fibrillation management strategies

Moderator: Leslie McDonogh
Session Chair: Hussam Hamdalla, MD

Objectives:

• Summarize specific echocardiographic assessments required for mitral valve repair
• Formulate echocardiographic evaluations for left ventricular assist device surgery in the OR
• Discuss unique echocardiographic measurements of aortic dissection repair in the OR

Session Chairs: Marcus Stoddard, MD and Michelle Bay, ACS, RDCS, FAS

Session Chairs: Marcus Stoddard, MD and Michelle Bay, ACS, RDCS, FAS

Session Chairs: Marcus Stoddard, MD and Michelle Bay, ACS, RDCS, FAS

Session Chairs: Marcus Stoddard, MD and Michelle Bay, ACS, RDCS, FAS

Objectives:

• Review the current guidelines and requirements for a complete assessment of the Tricuspid Valve
• Discuss the importance of a thorough evaluation of the Tricuspid Valve
• Review tips and techniques to improve image quality of the Tricuspid Valve

Moderator: John Kotter, MD
Session Chair: John Kotter, MD

Objectives:

• Review techniques to perform a hemodynamic assessment using echocardiography
• Discuss pitfalls encountered when performing an echocardiographic hemodynamic assessment
• Work through a case-based example of an echocardiographic hemodynamic assessment

Moderator: John Kotter, MD
Session Chair: John Kotter, MD

Objectives:

• Review standard measures of right heart chamber size
• Identify diagnostic and prognostic echo findings in VTE function
• Review illustrative case examples

Moderator: Arash Seratnahaei, MD
Session Chair: Arash Seratnahaei, MD

Objectives:

• To gain insight into the relationship between right ventricular structure and function.
• To explore current echocardiographic methods for measuring right ventricular function.
• To review current echocardiographic imaging guidelines regarding right ventricular structure and function.

Moderator: Arash Seratnahaei, MD
Session Chair: Arash Seratnahaei, MD

Objectives:

• Understand the histroy of tetralogy of fallot
• Understand the basic embryology of tetralogy of fallot
• Understand the anatomic variability of tetralogy of fallot

Moderator: Juan Villafane, MD
Session Chair: Juan Villafane, MD

Objectives:

• Review the complete echocardiographic assessment of tetralogy of Fallot
• Describe the associated lesions and their diagnostic methods

Moderator: Juan Villafane, MD
Session Chair: Juan Villafane, MD

Objectives:

• Evaluate the role of advanced imaging in planning surgical interventions for TOF

Moderator: Juan Villafane, MD
Session Chair: Juan Villafane, MD

Moderator: Juan Villafane, MD
Session Chair: Juan Villafane, MD

Objectives:

• Surgical techniques related to treatment of tetralogy of fallot

Moderator: James Quintessenza, MD
Session Chair: Andrew Leventhal, MD, PhD

Moderator: James Quintessenza, MD
Session Chair: Andrew Leventhal, MD, PhD

Moderator: James Quintessenza, MD
Session Chair: Andrew Leventhal, MD, PhD

Objectives:

• Distinguish WHO Group 1 pulmonary arterial hypertension (PAH) from other causes of pulmonary hypertension
• Briefly discuss presentation and diagnosis of PAH
• Discuss treatment strategies in WHO Group 4 pulmonary hypertension, or chronic thromboembolic pulmonary hypertension (CTEPH)
• Discuss emerging treatment strategies in PAH

Session Chair: Andrew Kolodziej, MD

Objectives:

• Review indications for CPET/CPX
• Understand how CPET/CPX is performed
• Learn how to interpret CPET/CPX

Session Chair: Emma Birks, MD, PhD, FRCP

Objectives:

• Understand the therapeutic targets of medications used in the treatment of pulmonary artery hypertentsion (PAH)
• Describe current literature in PAH treatment using early combination medication therapy
• Create a pharmacotherapy plan for implementing combination therapy in PAH patients that improves patient symptoms while minimizing adverse effects

Session Chair: Emma Birks, MD, PhD, FRCP

Objectives:

• Epidemeology of pulmonary embolism (PE)
• Medical management of PE
• Invasive management of PE
• Future directions in treatment of PE

Moderator: Michael Faulkner, MD
Session Chair: Kevin Parrot, MD

Objectives:

• Understand current guideline recommendations for antiplatelet therapy post-PCI
• Given patient case be able to evaluate bleeding and ischemic risks
• Individualize antiplatelet therapy, drug and duration, based on available evidence and guideline recommendations

Moderator: Michael Faulkner, MD
Session Chair: Kevin Parrot, MD

Moderator: Leslie McDonogh
Session Chair: Hussam Hamdalla, MD

Moderator: Leslie McDonogh
Session Chair: Hussam Hamdalla, MD

Objectives:

• Educate on a variety of topics in a fun and interactive way